search
Back to results

Effects of Caffeine and Intermittent Hypoxia on Leg Function in Human Spinal Cord Injury

Primary Purpose

Spinal Cord Injuries

Status
Completed
Phase
Phase 1
Locations
United States
Study Type
Interventional
Intervention
Caffeine
AIH
Placebo
SHAM
Sponsored by
Spaulding Rehabilitation Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Spinal Cord Injuries focused on measuring hypoxia, spinal cord injury, rehabilitation, strength, walk, function, low oxygen

Eligibility Criteria

18 Years - 75 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • age 18 and 75 years (the latter to reduce likelihood of heart disease)
  • medical clearance to participate
  • lesion at or below C2 and above L5 with non-progressive etiology
  • classified as motor-incomplete with visible volitional leg movement
  • injury greater than 6 months
  • ability to advance one step overground without human assistance

Exclusion Criteria:

  • Concurrent severe medical illness (i.e., infection, cardiovascular disease, ossification, recurrent autonomic dysreflexia, unhealed decubiti, and history of pulmonary complications)
  • Pregnant women because of the unknown affects of AIH on pregnant women and fetus
  • History of seizures, brain injury, and/or epilepsy
  • Undergoing concurrent physical therapy
  • Diabetes
  • Cirrhosis
  • Caffeine and/or NSAID allergies or intolerances

Sites / Locations

  • Spaulding Rehabilitation Hospital

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Active Comparator

Active Comparator

Active Comparator

Arm Label

Caffeine/AIH

Placebo/AIH

Caffeine/SHAM

Arm Description

Subjects with chronic, motor-incomplete SCI receive Caffeine then AIH

Subjects with chronic, motor-incomplete SCI receive Placebo then AIH

Subjects with chronic, motor-incomplete SCI receive Caffeine then SHAM

Outcomes

Primary Outcome Measures

10 Meter Walk Time
Speed will be assessed using the time required to walk 10 meters (10MWT) relative to baseline.

Secondary Outcome Measures

6 Minute Walk Test
Measure participant's distance walked in 6 minutes (meters).

Full Information

First Posted
December 18, 2014
Last Updated
August 8, 2022
Sponsor
Spaulding Rehabilitation Hospital
Collaborators
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
search

1. Study Identification

Unique Protocol Identification Number
NCT02323698
Brief Title
Effects of Caffeine and Intermittent Hypoxia on Leg Function in Human Spinal Cord Injury
Official Title
The Effects of Intermittent Hypoxia on Leg Function in Human Spinal Cord Injury (Caffeine Substudy)
Study Type
Interventional

2. Study Status

Record Verification Date
August 2022
Overall Recruitment Status
Completed
Study Start Date
January 1, 2019 (Actual)
Primary Completion Date
March 19, 2021 (Actual)
Study Completion Date
February 19, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Spaulding Rehabilitation Hospital
Collaborators
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

4. Oversight

Studies a U.S. FDA-regulated Drug Product
Yes
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Accumulating evidence suggests that repeatedly breathing low oxygen levels for brief periods (termed intermittent hypoxia) is a safe and effective treatment strategy to promote meaningful functional recovery in persons with chronic spinal cord injury (SCI). The goal of the study is to understand how caffeine may augment the effects of intermittent hypoxia on motor function and spinal plasticity (ability of the nervous system to strengthen neural pathways based on new experiences) following SCI.
Detailed Description
The investigators will examine the effects of acute intermittent hypoxia (AIH) as a possible therapeutic intervention to promote functionally useful motor recovery. In this sub-study, the investigators will assess changes in leg motor function in response to repetitive AIH with and without caffeine. Participants will receive caffeine+AIH, placebo+AIH, caffeine+SHAM in a randomized order. Before each intervention round, subjects will be asked to avoid caffeine-containing substances for 48 hrs (> 5* half-life of ~7 hrs) prior to arrival to control for baseline plasma levels of caffeine. Subjects will then ingest capsules containing either placebo (dextrose) or caffeine (up to 6mg/kg). Capsules will be prepared by Johnson Compounding & Wellness. Blood samples will be collected before and after the breathing intervention to assess caffeine concentrations within the body. During and after each intervention, both the rate and extent of magnitude changes in voluntary and involuntary muscle response behaviors important for walking will be compared between interventions within participants. Repeated measurements will be collected on all subjects that participate in the multiple interventions.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Spinal Cord Injuries
Keywords
hypoxia, spinal cord injury, rehabilitation, strength, walk, function, low oxygen

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 1, Phase 2
Interventional Study Model
Crossover Assignment
Model Description
Balanced design
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
36 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Caffeine/AIH
Arm Type
Active Comparator
Arm Description
Subjects with chronic, motor-incomplete SCI receive Caffeine then AIH
Arm Title
Placebo/AIH
Arm Type
Active Comparator
Arm Description
Subjects with chronic, motor-incomplete SCI receive Placebo then AIH
Arm Title
Caffeine/SHAM
Arm Type
Active Comparator
Arm Description
Subjects with chronic, motor-incomplete SCI receive Caffeine then SHAM
Intervention Type
Drug
Intervention Name(s)
Caffeine
Other Intervention Name(s)
caffeine anhydrous
Intervention Description
Subjects will ingest capsules containing caffeine (up to 6mg/kg). Experiments will begin 30min after consumption to approximately coincide with peak plasma concentrations.Throughout the 30min wait time and experimentation, blood pressure and heart rate will be monitored.
Intervention Type
Other
Intervention Name(s)
AIH
Other Intervention Name(s)
Acute intermittent hypoxia
Intervention Description
Participants will breathe intermittent low oxygen via air generators. The generators will fill reservoir bags attached to a non-rebreathing face mask. Oxygen concentration will be continuously monitored to ensure delivery of FIO2 (fraction of inspired oxygen) = 0.10±0.02 (hypoxia). Throughout experimentation, blood pressure and heart rate will be monitored.
Intervention Type
Other
Intervention Name(s)
Placebo
Intervention Description
This is a placebo counterpart to the caffeine drug. Subjects will ingest capsules containing dextrose. Experiments will begin 30min after consumption to mimic the caffeine drug protocol. Throughout experimentation, blood oxygenation, blood pressure and heart rate will be monitored.
Intervention Type
Other
Intervention Name(s)
SHAM
Intervention Description
This is a placebo counterpart to breathing intermittent low oxygen. Participants will breathe intermittent room air via air generators. The generators will fill reservoir bags attached to a non-rebreathing face mask. Oxygen concentration will be continuously monitored to ensure delivery of FIO2 (fraction of inspired oxygen) = 0.21±0.02 (normoxia). Throughout experimentation, blood pressure and heart rate will be monitored.
Primary Outcome Measure Information:
Title
10 Meter Walk Time
Description
Speed will be assessed using the time required to walk 10 meters (10MWT) relative to baseline.
Time Frame
Baseline, after intervention (day 5), and at follow-ups (one week and two weeks)
Secondary Outcome Measure Information:
Title
6 Minute Walk Test
Description
Measure participant's distance walked in 6 minutes (meters).
Time Frame
Baseline, after intervention (day 5), and at follow-ups (one week and two weeks)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: age 18 and 75 years (the latter to reduce likelihood of heart disease) medical clearance to participate lesion at or below C2 and above L5 with non-progressive etiology classified as motor-incomplete with visible volitional leg movement injury greater than 6 months ability to advance one step overground without human assistance Exclusion Criteria: Concurrent severe medical illness (i.e., infection, cardiovascular disease, ossification, recurrent autonomic dysreflexia, unhealed decubiti, and history of pulmonary complications) Pregnant women because of the unknown affects of AIH on pregnant women and fetus History of seizures, brain injury, and/or epilepsy Undergoing concurrent physical therapy Diabetes Cirrhosis Caffeine and/or NSAID allergies or intolerances
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Randy D Trumbower, PT, PhD
Organizational Affiliation
Harvard Medical School (HMS and HSDM)
Official's Role
Principal Investigator
Facility Information:
Facility Name
Spaulding Rehabilitation Hospital
City
Cambridge
State/Province
Massachusetts
ZIP/Postal Code
02138
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
30009669
Citation
Trumbower RD. Stimulating the Injured Spinal Cord: Plenty to Grasp. J Neurotrauma. 2018 Sep 15;35(18):2143-2144. doi: 10.1089/neu.2018.5993. No abstract available.
Results Reference
background
PubMed Identifier
29648987
Citation
Sohn WJ, Tan AQ, Hayes HB, Pochiraju S, Deffeyes J, Trumbower RD. Variability of Leg Kinematics during Overground Walking in Persons with Chronic Incomplete Spinal Cord Injury. J Neurotrauma. 2018 Nov 1;35(21):2519-2529. doi: 10.1089/neu.2017.5538. Epub 2018 Jun 5.
Results Reference
background
PubMed Identifier
28972191
Citation
Trumbower RD, Hayes HB, Mitchell GS, Wolf SL, Stahl VA. Effects of acute intermittent hypoxia on hand use after spinal cord trauma: A preliminary study. Neurology. 2017 Oct 31;89(18):1904-1907. doi: 10.1212/WNL.0000000000004596. Epub 2017 Sep 29.
Results Reference
background
PubMed Identifier
28762876
Citation
Peters DM, Thibaudier Y, Deffeyes JE, Baer GT, Hayes HB, Trumbower RD. Constraints on Stance-Phase Force Production during Overground Walking in Persons with Chronic Incomplete Spinal Cord Injury. J Neurotrauma. 2018 Feb 1;35(3):467-477. doi: 10.1089/neu.2017.5146. Epub 2017 Oct 27.
Results Reference
background
PubMed Identifier
24618214
Citation
Hayes HB, Chvatal SA, French MA, Ting LH, Trumbower RD. Neuromuscular constraints on muscle coordination during overground walking in persons with chronic incomplete spinal cord injury. Clin Neurophysiol. 2014 Oct;125(10):2024-35. doi: 10.1016/j.clinph.2014.02.001. Epub 2014 Feb 14.
Results Reference
background
PubMed Identifier
24285617
Citation
Hayes HB, Jayaraman A, Herrmann M, Mitchell GS, Rymer WZ, Trumbower RD. Daily intermittent hypoxia enhances walking after chronic spinal cord injury: a randomized trial. Neurology. 2014 Jan 14;82(2):104-13. doi: 10.1212/01.WNL.0000437416.34298.43. Epub 2013 Nov 27.
Results Reference
background
Links:
URL
http://inspire-lab.org
Description
INSPIRE Lab Website

Learn more about this trial

Effects of Caffeine and Intermittent Hypoxia on Leg Function in Human Spinal Cord Injury

We'll reach out to this number within 24 hrs